Study Portfolio
Active studies, enrollment progress and milestone risk
Active Studies
48
Patients Enrolled
13,964
Enrollment vs Plan
86%
Below 90% target
High Risk Milestones
3
547 active sites
Active Studies by Phase and Therapeutic Area
Cumulative Enrollment vs Plan
Milestones at Risk
| Study | Therapeutic Area | Milestone | Due | Projected Slip (days) | Risk |
|---|---|---|---|---|---|
| MCR-ONC-101 | Oncology | Database lock | May 2026 | 17 | Medium |
| MCR-CAR-108 | Cardiology | First patient in | Feb 2026 | 60 | Medium |
| MCR-NEU-115 | Neurology | CSR delivery | Feb 2026 | 62 | High |
| MCR-IMM-122 | Immunology | CSR delivery | Mar 2026 | 28 | Medium |
| MCR-INF-129 | Infectious Disease | CSR delivery | Oct 2026 | 48 | Medium |
| MCR-ONC-136 | Oncology | CSR delivery | Jul 2026 | 26 | High |
| MCR-CAR-143 | Cardiology | Interim analysis | Oct 2026 | 21 | High |